Irkutsk, Irkutsk region, Russian Federation
Irkutsk, Irkutsk region, Russian Federation
The 95 cases of adverse drug reactions in children were registered in the Centre of Drug Safety Monitoring of Irkutsk Region from 2009 to 2015. In 21.4 % of cases, the coexistent affections developed. Children were allergic three times more often than adults. In 14.7 % of cases severe allergic reactions were registered. Most often allergies occurred after taking immunotropic (62.2 %), antimicrobial (16.2 %) and nonsteroidal anti-inflammatory drugs (10.8 %). 10.5 % of cases concerned inefficient drug use in children under 3 years; and 36.8 % of cases concerned children aged 3 to 18 years. The following risk factors of inefficient antibiotic therapy in children with urinary system infections were determined: the duration of the disease up to 5 years, isolation of two or more infectious agents and concomitant infections of upper and lower urinary tract. Adverse drug reaction occurred more often when more than three drugs were prescribed at the same time. Such cases were generally registered in patients with infectious diseases and epilepsy. Risk of adverse reaction increased with the off-label drug use. Introduction of monitoring methods and prediction algorithms allowing to reveal with high probability and to prevent adverse drug reactions in children improved efficiency and quality of pharmacotherapy.
children, drug reaction, drugs, safety monitoring, adv erse drug reaction
1. Belousov AA, Gratsianskaya AN (2008). Clinical studies in clinical practice [Klinicheskie issledovaniya v klinicheskoy praktike]. Kachestvennaya klinicheskaya praktika, (2), 22-23.
2. Belousov AA, Kukes VG, Lepakhin VK, Petrov VI (2014). Clinical pharmacology. National guideline [Klinicheskaya farmakologiya. Natsional’noe rukovodstvo], 976.
3. Verlan NV, Rybalko MV, Dvoynikovа NA, Kochkina EO, Gumennikova EN (2013). Problems of drug safety monitoring [Problemy monitoringa bezopasnogo ispol’zovaniya lekarstvennykh sredstv]. Sibirskiy meditsinskiy zhurnal (Irkutsk), (6), 113-114.
4. Verlan NV, Kochkina EO, Dvoynikova NA, Rybalko MV, Popadyuk AV (2014). Drug safety monitoring [Provedenie monitoringa bezopasnosti lekarstvennykh sredstv]. Vestnik Buryatskogo gosudarstvennogo universiteta. Seriya: Meditsina, farmatsiya, 12, 13-16.
5. Doskin VA, Zaprudov AM (2012). Analysis of modern problems of clinical pharmacology and pharmacotherapy in pediatrics [Analiz sovremennykh problem klinicheskoy farmakologii i farmakoterapii v pediatrii]. Rossiyskiy vestnik perinatologii i pediatrii, (3), 5-11.
6. Kosenko VV, Glagolev SV (2012). Organization of the safety monitoring system of registered drugs in the Russian Federation [Organizatsiya sistemy monitoringa bezopasnosti zaregistrirovannykh lekarstvennykh preparatov v Rossiyskoy Federatsii]. Vestnik Roszdravnadzora, (5), 25-26.
7. Kostyleva MN, Belousov YuB, Gratsianskaya AN, Postnikov SS (2014). Assessment of drug therapy safety in clinical practice [Otsenka bezopasnosti lekarstvennoy terapii v klinicheskoy praktike]. Farmakoekonomika, (1), 26-31.
8. Tatochenko VK (2007). To a pediatrician for every day (annual guidelines) [Pediatru na kazhdyy den’], 272.
9. Shabalov NP (2007). Childhood diseases [Detskie bolezni], 63.
10. Rashed AN, Wong IC, Cranswick N et al. (2012). Risk factors associated with adverse drug reactions in hospitalized children: international multicentre study. Eur. J. Clin. Pharmac., 68 (5), 801-810.
